Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
The Journal of Organic Chemistry|December 2, 2006
Chemoselective protection of solid-phase compatible Fmoc-phosphinic building blocksMagdalini Nasopoulou, Magdalini Matziari, Vincent Dive, et al.The Journal of Physical Chemistry. B|December 18, 2009
Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solventsMagdalini Matziari, Dimitris Dellis, Vincent Dive, et al.The Journal of Organic Chemistry|August 25, 2007
A versatile annulation protocol toward novel constrained phosphinic peptidomimeticsMagdalini Nasopoulou, Dimitris Georgiadis, Magdalini Matziari, et al.Journal of Medicinal Chemistry|January 9, 2004
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11Magdalini Matziari, Fabrice Beau, Philippe Cuniasse, et al.Biochemistry|June 24, 2004
Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domainDimitris Georgiadis, Philippe Cuniasse, Jöel Cotton, et al.Current Pharmaceutical Design|November 21, 2009
Inhibition of zinc metallopeptidases in cardiovascular disease--from unity to trinity, or duality?Vincent Dive, Cheng-Fu Chang, Athanasios Yiotakis, et al.The FEBS Journal|April 21, 2006
Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzymeNicolas D Jullien, Philippe Cuniasse, Dimitris Georgiadis, et al.Journal of Medicinal Chemistry|November 11, 2009
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitorsNicolas Jullien, Anastasios Makritis, Dimitris Georgiadis, et al.Journal of Medicinal Chemistry|March 8, 2008
Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2Andreas Mores, Magdalini Matziari, Fabrice Beau, et al.Circulation Research|June 14, 2003
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitorsDimitris Georgiadis, Fabrice Beau, Bertrand Czarny, et al.Pageof 4